Schrenk D, Buchmann A, Dietz K, Lipp H P, Brunner H, Sirma H, Münzel P, Hagenmaier H, Gebhardt R, Bock K W
Institut für Toxikologie, Universität Tübingen, Germany.
Carcinogenesis. 1994 Mar;15(3):509-15. doi: 10.1093/carcin/15.3.509.
In a two-stage initiation-promotion experiment the hypothesis was investigated that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) equivalents (TE), calculated from data of CYP1A induction in hepatocytes in primary culture, or international TCDD equivalents (ITE) are useful for evaluating the tumor-promoting potency of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) and of a defined mixture (M2) of 49 polychlorinated dibenzo-p-dioxins (PCDDs) in comparison with TCDD. Therefore, female Wistar rats were treated with an initiating dose of N-nitrosomorpholine, and subsequently received daily doses of 2, 20 and 200 ng TCDD/kg or equivalent doses of HpCDD or M2, based on TE values. After a promotion phase of 13 weeks, hepatic PCDD levels, CYP1A activity and the relative hepatic volume of adenosinetriphosphatase-negative or glutathione S-transferase P-positive preneoplastic foci were determined. After logarithmic transformation, linear PCDD level-response relationships were obtained for induction of CYP1A activity with TCDD, HpCDD or M2. Based on TE values, inducing potencies of both HpCDD and M2 were over-estimated at higher doses, whereas induction was approximately equivalent at the lowest dose. The best fit of PCDD level-response relationships of relative hepatic volumes of preneoplastic lesions was achieved using a four-parameter logistic model. Significantly different functions were calculated for promotion with TCDD or HpCDD. It is concluded that (i) different PCDD level-response relationships exist for the induction of hepatic CYP1A activity and the promotion of preneoplastic liver foci, and (ii) that TE or ITE factors provide only a rough estimate of the tumor-promoting potency of a PCDD mixture but may overestimate the risk from exposure to higher-chlorinated 2,3,7,8-substituted congeners such as HpCDD.
在一项两阶段启动-促癌实验中,对如下假设进行了研究:根据原代培养肝细胞中CYP1A诱导数据计算得出的2,3,7,8-四氯二苯并-对-二噁英(TCDD)当量(TE)或国际TCDD当量(ITE),对于评估1,2,3,4,6,7,8-七氯二苯并-对-二噁英(HpCDD)以及49种多氯二苯并-对-二噁英(PCDD)的特定混合物(M2)与TCDD相比的促癌效力是否有用。因此,对雌性Wistar大鼠给予亚硝基吗啉的启动剂量,随后根据TE值每日给予2、20和200 ng TCDD/kg或等量剂量的HpCDD或M2。在13周的促癌阶段后,测定肝脏PCDD水平、CYP1A活性以及三磷酸腺苷阴性或谷胱甘肽S-转移酶P阳性的癌前病灶的相对肝脏体积。经过对数转换后,得出了TCDD、HpCDD或M2诱导CYP1A活性的线性PCDD水平-反应关系。基于TE值,在较高剂量下,HpCDD和M2的诱导效力均被高估,而在最低剂量下诱导作用大致相当。使用四参数逻辑模型实现了癌前病变相对肝脏体积的PCDD水平-反应关系的最佳拟合。计算得出TCDD或HpCDD促癌的显著不同函数。得出的结论是:(i)肝脏CYP1A活性的诱导和癌前肝病灶的促癌存在不同的PCDD水平-反应关系;(ii)TE或ITE因子仅提供PCDD混合物促癌效力的粗略估计,但可能高估了接触高氯代2,3,7,8-取代同系物(如HpCDD)的风险。